Cargando…

Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model

Helicobacter pylori is the most prevalent pathogen causing chronic gastritis, gastroduodenal ulcers, and gastric tumors and is asymptomatically present in 50% of the world's population. This research is focused on investigating the effect of Lactobacillus paracasei ZFM 54 (CCTCC NO:2016667) on...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhou, Qingqing, Qureshi, Nuzhat, Xue, Bingyao, Xie, Zuorui, Li, Ping, Gu, Qing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449542/
https://www.ncbi.nlm.nih.gov/pubmed/36091249
http://dx.doi.org/10.3389/fnut.2022.972569
_version_ 1784784323738599424
author Zhou, Qingqing
Qureshi, Nuzhat
Xue, Bingyao
Xie, Zuorui
Li, Ping
Gu, Qing
author_facet Zhou, Qingqing
Qureshi, Nuzhat
Xue, Bingyao
Xie, Zuorui
Li, Ping
Gu, Qing
author_sort Zhou, Qingqing
collection PubMed
description Helicobacter pylori is the most prevalent pathogen causing chronic gastritis, gastroduodenal ulcers, and gastric tumors and is asymptomatically present in 50% of the world's population. This research is focused on investigating the effect of Lactobacillus paracasei ZFM 54 (CCTCC NO:2016667) on attenuating H. pylori-induced gastritis. H. pylori ZJC03 isolated from a patient with gastritis harbored the virulence genes of vacA and cagA and was highly resistant to metronidazole (MIC > 256 μg/mL). In vitro analysis revealed that the potential anti-H. pylori characteristics of L. paracasei ZFM54 in terms of 65.57 ± 1.87% survival rate in simulated gastric juices at a pH of 2.0, 69.00 ± 2.73% auto-aggregation, 30.28 ± 2.24% co-aggregation, 70.27 ± 2.23% urease inhibition, and 57.89 ± 1.27% radical scavenging. In H. pylori infectious mice, L. paracasei ZFM54 pre- and post-treatment reduced the levels of malondialdehyde in liver tissues to 0.71 ± 0.04 nmol/mgprot (p < 0.05) and 0.70 ± 0.06 nmol/mgprot (p < 0.05), respectively. Glutathione levels were increased to 1.78 ± 0.02 μmol/gprot (p < 0.05) and 1.76 ± 0.52 μmol/gprot (p < 0.05), respectively. L. paracasei ZFM54 significantly inhibited H. pylori-mediated inflammation observed in gastric mucosal repair and downregulated the mRNA expression of pro-inflammatory cytokines IFN-γ, IL-1β, and IL-6 (p < 0.01). Importantly, L. paracasei ZFM54 increased Firmicutes and Actinobacteriota and decreased the relative abundance of bacterial taxa belonging to Campilobacterota and Proteobacteria. With the preventive and therapeutic administration of L. paracasei ZFM54, significant reductions in the average relative abundance of genera Helicobacter, Muribaculum, Staphylococcus, Lachnospiraceae_NK4A136_group, Prevotellaceae_UCG-001, Alloprevotella, and Oscillibacter were observed compared to infected mice. These findings suggest that L. paracasei ZFM 54 has the potential to protect against H. pylori infection by ameliorating inflammation and restoring the gastric microbiota.
format Online
Article
Text
id pubmed-9449542
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94495422022-09-08 Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model Zhou, Qingqing Qureshi, Nuzhat Xue, Bingyao Xie, Zuorui Li, Ping Gu, Qing Front Nutr Nutrition Helicobacter pylori is the most prevalent pathogen causing chronic gastritis, gastroduodenal ulcers, and gastric tumors and is asymptomatically present in 50% of the world's population. This research is focused on investigating the effect of Lactobacillus paracasei ZFM 54 (CCTCC NO:2016667) on attenuating H. pylori-induced gastritis. H. pylori ZJC03 isolated from a patient with gastritis harbored the virulence genes of vacA and cagA and was highly resistant to metronidazole (MIC > 256 μg/mL). In vitro analysis revealed that the potential anti-H. pylori characteristics of L. paracasei ZFM54 in terms of 65.57 ± 1.87% survival rate in simulated gastric juices at a pH of 2.0, 69.00 ± 2.73% auto-aggregation, 30.28 ± 2.24% co-aggregation, 70.27 ± 2.23% urease inhibition, and 57.89 ± 1.27% radical scavenging. In H. pylori infectious mice, L. paracasei ZFM54 pre- and post-treatment reduced the levels of malondialdehyde in liver tissues to 0.71 ± 0.04 nmol/mgprot (p < 0.05) and 0.70 ± 0.06 nmol/mgprot (p < 0.05), respectively. Glutathione levels were increased to 1.78 ± 0.02 μmol/gprot (p < 0.05) and 1.76 ± 0.52 μmol/gprot (p < 0.05), respectively. L. paracasei ZFM54 significantly inhibited H. pylori-mediated inflammation observed in gastric mucosal repair and downregulated the mRNA expression of pro-inflammatory cytokines IFN-γ, IL-1β, and IL-6 (p < 0.01). Importantly, L. paracasei ZFM54 increased Firmicutes and Actinobacteriota and decreased the relative abundance of bacterial taxa belonging to Campilobacterota and Proteobacteria. With the preventive and therapeutic administration of L. paracasei ZFM54, significant reductions in the average relative abundance of genera Helicobacter, Muribaculum, Staphylococcus, Lachnospiraceae_NK4A136_group, Prevotellaceae_UCG-001, Alloprevotella, and Oscillibacter were observed compared to infected mice. These findings suggest that L. paracasei ZFM 54 has the potential to protect against H. pylori infection by ameliorating inflammation and restoring the gastric microbiota. Frontiers Media S.A. 2022-08-24 /pmc/articles/PMC9449542/ /pubmed/36091249 http://dx.doi.org/10.3389/fnut.2022.972569 Text en Copyright © 2022 Zhou, Qureshi, Xue, Xie, Li and Gu. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Nutrition
Zhou, Qingqing
Qureshi, Nuzhat
Xue, Bingyao
Xie, Zuorui
Li, Ping
Gu, Qing
Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title_full Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title_fullStr Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title_full_unstemmed Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title_short Preventive and therapeutic effect of Lactobacillus paracasei ZFM54 on Helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
title_sort preventive and therapeutic effect of lactobacillus paracasei zfm54 on helicobacter pylori-induced gastritis by ameliorating inflammation and restoring gastric microbiota in mice model
topic Nutrition
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9449542/
https://www.ncbi.nlm.nih.gov/pubmed/36091249
http://dx.doi.org/10.3389/fnut.2022.972569
work_keys_str_mv AT zhouqingqing preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel
AT qureshinuzhat preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel
AT xuebingyao preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel
AT xiezuorui preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel
AT liping preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel
AT guqing preventiveandtherapeuticeffectoflactobacillusparacaseizfm54onhelicobacterpyloriinducedgastritisbyamelioratinginflammationandrestoringgastricmicrobiotainmicemodel